Mersana Therapeutics (MRSN) Provides Statement About SVB

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. SPCX
2. HUM
3. ALHC
4. PEP
5. T
6. SPY
7. CVS
8. UNH
9. TMUS
10. VZ

Go back to Mersana Therapeutics (MRSN) Provides Statement About SVB

Mersana Therapeutics Provides Statement About SVB

March 10, 2023 7:10 PM EST

CAMBRIDGE, Mass., March 10, 2023 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today provided an update about its capital resources. A de minimis amount of Mersanas capital is currently held in a checking account at Silicon Valley Bank (SVB). The balance of the companys capital resources is held in a custodial account managed... More